EP3139948
TREATMENT OF DIABETES TYPE 1 USING GLP-1 AND ANTI-IL-21
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.5.2015EP published:
4.3.2020EP application number:
15720982.6
EPO information:
European Patent Register
Max expiry date:
4.5.2035
Title:
TREATMENT OF DIABETES TYPE 1 USING GLP-1 AND ANTI-IL-21
Timeline
Today
5.5.2015EP application
4.3.2020EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880 Bagsværd, DK
Inventor
Name:
COPPIETERS, KenAddress:
2880 Bagsværd, DK
Name:
VON HERRATH, MatthiasAddress:
Seattle, Washington 98109, US
Name:
BOURSALIAN, TamarAddress:
Seattle, Washington 98109, US
Priority
Number:
201461989841 PDate:
7.5.2014Country:
US
Number:
14169596Date:
23.5.2014Country:
EP
Number:
14189732Date:
21.10.2014Country:
EP
Classification
Categories:
A61K 38/26, A61K 39/395, A61P 3/10, C07K 16/24, A61K 39/00